Lead time and overdiagnosis

Journal of the National Cancer Institute

Volumn 106, Issue 12, 2014, Pages

  Baker, Stuart G ^a   Prorok, Philip C ^a   Kramer, Barnett S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; MAMMOGRAPHY; MATHEMATICAL MODEL; PRIORITY JOURNAL; REVIEW; BREAST NEOPLASMS; EARLY DIAGNOSIS; FEMALE; HUMAN; MASS SCREENING;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING;

EID: 84922393700     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju346     Document Type: Review

References (10)

1. Etzioni R, Xia J, Hubbard R, Weiss NS, Gulati R. A reality check for overdiagnosis estimates associated with breast cancer screening. J Natl Cancer Inst. 2014; In press.
2. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-613.
3. Horii R, Akiyama F, Kasumi F, Koike M, Sakamoto G. Spontaneous "healing" of breast cancer. Breast Cancer. 2005;12(2):140-144.
4. Baker, SG. Recognizing paradigm instability in theories of carcinogenesis. British J Med Med Res. 2014:4:1149-1163.
5. Zelen M, Feinleib M. On the theory of screening for chronic diseases. Biometrika. 1969;56(3):601-614.
6. Day NE, Walter SD. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics. 1984;40(1):1-14.
7. Arias E. United States Life Tables, 2009. Nat Vital Stat Rep. 2014;62(7):9-10.
8. Bleyer A, Welch HG. Effects of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998-2005.
9. Connor RJ, Prorok PC. Issues in the mortality analysis of randomized controlled trials of cancer screening. Control Clin Trials. 1994;15(2):81-99.
10. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ. 1988;297(6654):943-948.